SAVA - Why Small Biotech Stocks Top List of Potential Outperformers this Fall (GTHX ATRX SRPT MGNX CPRX CLDX BDSI SAVA)
The smaller cap biotech space offers two key advantages for investors right now: cyclical diversification and diversification away from the vaccine monolithic theme. To break that down a bit, the stock market has been volatile over the past month, with many growth plays getting smacked down as risk comes off the table with Wall Street […]
For further details see:
Why Small Biotech Stocks Top List of Potential Outperformers this Fall (GTHX, ATRX, SRPT, MGNX, CPRX, CLDX, BDSI, SAVA)